Status:
TERMINATED
To Evaluate if the Medication Gabapentin Lessens Vulvar Pain
Lead Sponsor:
Colleen Stockdale
Conditions:
Vulvar Pain Symptoms
Vulvodynia (Chronic Vulvar Pain)
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.
Detailed Description
There is not a "best" treatment plan for vulvar pain including vulvodynia (chronic vulvar pain) and vulvar vestibulitis syndrome (VVS, chronic vulvar pain localized to the vaginal opening). We propose...
Eligibility Criteria
Inclusion
- All women, ages 18 years and older with the diagnosis of vulvodynia or VVS (by Friedrich's criteria), who present to the University of Iowa Vulvar Vaginal Disease Clinic.
Exclusion
- Vulvar Vaginal Disease clinic patients who are pregnant, less than 3 months postpartum, breast-feeding, non-English speaking, or have contraindication to use of gabapentin due to allergy or renal disease (serum creatinine level greater than 1.4).
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00390013
Start Date
January 1 2007
End Date
March 1 2008
Last Update
July 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States, 52242